(RTTNews) - Protara Therapeutics, Inc. (TARA) announced the FDA has granted Fast Track designation to Intravenous Choline Chloride, the investigational IV phospholipid substrate replacement ...

s (NASDAQ:TARA) investigational therapy, Intravenous (IV) Choline Chloride, for patients requiring parenteral support. This designation is aimed at expediting the development and review of drugs ...

NEW YORK - The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Protara Therapeutics, Inc.'s (NASDAQ:TARA) investigational therapy, Intravenous (IV) Choline Chloride, for ...

After hours: October 24 at 7:41 PM EDT Loading Chart for SGML ...

The traditional full line pharmacy wholesale distribution business, retail and private label products. Also has national Presence in the hospital pharmacy distribution market, and through its ...

Book Abstract: This comprehensive guide offers a detailed treatment of the analysis, design, simulation and testing of the full range of today's leading delta-sigma data converters. Written by ...

HyperSIGMA is the first billion-level foundation model specifically designed for HSI interpretation. To tackle the spectral and spatial redundancy challenges in HSIs, we introduce a novel sparse ...

Commonly marketed as an anti-aging product, nicotinamide riboside is an alternative form of vitamin B3 with few side effects. It may protect brain cells and lower the risk of heart disease. Every ...